Regardless of the mechanism(s) of disease pathogenesis, both systemic ALCL and BIA-ALCL share common oncogenic events; Jak1/STAT3 mutations are observed in systemic ALCL, ALK− and BIA-ALCL [54,55]. Here, JAK1 is linked to anaplastic large cell lymphoma.